内免疫疗法:一种方便和有效的替代品,用于皮下免疫治疗过敏性鼻炎
Tian Gu1,2, Wei Zhang1,2, Lu Tan1,2
1Department of Rhinology and Allergy, Otolaryngology-Head and Neck Surgery Center, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Research (Washington, D.C.)
|January 17, 2025
概括
内免疫疗法 (ITIT) 通过向免疫球蛋白E (IgE) 介导的疾病,为治疗过敏提供了一个更快,更安全的替代方案. 与传统方法相比,这种新的方法显示出更好的患者遵守性和更少的不良影响.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏学 过敏学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 过敏原特异性免疫疗法 (AIT) 是IgE介导过敏的唯一治愈治疗方法.
- 传统的皮下免疫疗法 (SCIT) 面临着诸多挑战,包括治疗时间长,患者服药不良以及不良反应.
研究的目的:
- 评价 intratonsillar免疫疗法 (ITIT) 作为一种新,有效和更安全的AIT途径.
- 在过敏性鼻炎 (AR) 患者中,将ITIT与SCIT进行比较.
主要方法:
- 对人类桃体样本进行免疫标记物 (IL-4,IL-21,IGE) 的分析.
- 在120名AR患者中,临床试验比较ITIT (2个月内3次注射) 与SCIT (1年).
- 评估临床症状,免疫细胞计数 (乙酸细胞,T细胞),细胞因子概况和不良事件.
主要成果:
- 桃体显示出比外围血液更高的过敏原特异性IgE.
- 与SCIT相比,ITIT提供了更快,更优质的症状缓解,特别是在年轻患者中.
- ITIT需要更少的剂量,减少乙氨基,增加调节性T细胞 (Treg,TFR) 和改善的细胞因子概况,具有最小的不良事件和高合规性.
结论:
- 内免疫疗法 (ITIT) 是一种有前途的替代性AIT,具有更高的疗效,安全性和方便性.
- ITIT比传统的SCIT更有效地解决了IgE介导过敏的根本原因.
- 对ITIT的进一步研究可能会彻底改变过敏治疗模式.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
217
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
217
01:30Acute Pharyngitis
399
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
399
01:17Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349